GB2065298A - Method and Apparatus for Detecting Biological Particles by Induced Signal - Google Patents

Method and Apparatus for Detecting Biological Particles by Induced Signal Download PDF

Info

Publication number
GB2065298A
GB2065298A GB7942836A GB7942836A GB2065298A GB 2065298 A GB2065298 A GB 2065298A GB 7942836 A GB7942836 A GB 7942836A GB 7942836 A GB7942836 A GB 7942836A GB 2065298 A GB2065298 A GB 2065298A
Authority
GB
United Kingdom
Prior art keywords
biological particle
biological
particle
substrate
exciting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7942836A
Other versions
GB2065298B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEI KUNG WANG
Original Assignee
WEI KUNG WANG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEI KUNG WANG filed Critical WEI KUNG WANG
Priority to GB7942836A priority Critical patent/GB2065298B/en
Publication of GB2065298A publication Critical patent/GB2065298A/en
Application granted granted Critical
Publication of GB2065298B publication Critical patent/GB2065298B/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated

Abstract

A metal-covered substrate 10 is first absorbed (covered) with a layer of known biological particles 12 such as a protein. This active substrate is then put into a solution containing an unknown amount of second biological particles whereby some of the second biological particles 13 are randomly bound in the layer. Third biological particles 14 are applied to the substrate. The third biological particles are chemically bound to a fluorescent label from which a signal may be induced in apparatus having an exciting particle or radiation source, and a detector to measure the amount of induced signal. In one embodiment the metal-covered substrate is positioned to redirect the exciting particle toward a trap and away from a detector. <IMAGE>

Description

SPECIFICATION Method and Apparatus Detecting Biological Particles by Induced Signal Background of the Invention This invention relates to immunological and specific binding detection of biological particles; more particularly this invention relates to detection of biological particles such as antibody, hormone, specific binding protein, receptor and antigen by fluorescent and metal label.
This invention relates to the subject matter of United States Patent No. 4,011,308 "Method for Surface Immunological Detection of Biological Particles by the use of Tagged Antibodies", and No. 3,926,564 "Substrate for Immunological Tests and Method Fabrication Thereof", both granted to I. Giaever. Other publications related to the present invention are "Blood Coagulation Studies with the Recording Ellipsometer" by I.
Vroman (National Bureau of Standards Miscellaneous Publication 256 September 1964); "A Study of Antigens and Antibodies by the Monolayer Film Technique of Langmuir" by M. F.
Shaffer and J. H. Dingle (Proceeding of Society of Experimental Biological Medicine 38, pages 528-530, 1938). "Immunological Reactions Between Film of Antigen and Antibody Molecule" by A. Rothen [Journal of Biological Chemistry Vol.
168 page 75-97 (April May1949,)); "The Beginnings of Immunofluorescence" by A. H.
Coons (J. Immunology 87 pages 499-503 (1961)) "Fluroescent Protein Conjugates" by R. F.
Steiner and H. Edelhoch (Chemistry Review 62, pages 457-483 (1962), and "Radioimmunoassay" by D. S. Skeller et al. [Clinical Chemistry 19(2) pages 146-186(1973)].
Immunological and specific binding reactions are highly specific biochemical reactions. The immunological reaction is vital in combatting diseases. The specific binding proteins and receptors are important in the transportation and balance of specific hormones, and molecules which affect the hormone function. To perform this kind of specific binding reaction on a metal surface, Shaffer et al., Rothen, and many other investigators have used ellipsometers to detect the amount of antibody bound to antigen or vice versa. Recently, Giaever has invented a visual detecting device using a specially prepared metal surface (see U. S. Patent No. 3926564). Because the signal is detected by the naked eye, the quantitative determination is somewhat arbitrary.
According to this invention, a metal surface is used. No special preparation of the metal surface is needed. Most metals prepared by evaporation using a commercially available heating or sputtering device will meet the necessary requirement for this invention and produce a highly reflective metal surface. The metal is used to bind a monomolecular layer ofprotein, for example containing an antigen, while the amount of antibody (second biological particle) bound to this antigen is determined by the induced emission from the label that is bound to an antibody (third biological particle) of this antibody.
The principal object of my invention is to provide an easy method and an apparatus to detect immunological or specific binding reactions. Another object of my invention is to provide an apparatus and an easy method to detect biological particles in a solution that may be serum, body secretion, body fluid, urine, tissue extraction etc. The biological particle may be a small particle like hormones, antibodies, plasma proteins, or a large particle like a virus, bacteria, cells, that are capable of stimulating antibody production. A further object of my invention is to provide an apparatus and simple method to perform diagnostic tests.In order to perform such a test, two appropriate biological particles with high mutual binding affinity must be found, one of them must be protein or protein bound (for example steroid hormone or polypeptide bound to bovine serum albumin) and the other a third biological particle, usually the antibody of the second biological particle. Because the novel apparatus according to the invention is used for quantitative signal detection, the metal surface need not be prepared from a particular kind of alloy or have a controlled thickness and the first biological particle, second biological particle and third biological need not form a layer so as to be detected. The preselected portein layer is absorbed on the surface of the substrate in a monomolecular layer (which includes first biological particle).When a suspect solution is tested for the presence or absence of the biological particle of interest (second biological particle), the monomolecular protein layer is placed in contact with the suspect solution for a sufficient long period of time to permit a specific binding reaction to occur. If the biological particle of interest is present, a specific reaction occurs between the initial protein layer and the biological particle of interest, resulting in some binding between them. This invention uses fluorescent or metal label to detect the amount of the second biological particle that is bound to the substrate.
Immunofluorescent stain has long been used in histochemistry to detect the presence of antigen.
In a traditional procedure, the antibody of the specific antigen is prepared and coupled with fluorescent dye. This fluorescent antibody is used as dye to stain a tissue slice, and a fluorescence microscope is used to visualize the existence of the specific antigen in the tissue. In this invention, we use the fluorescent antibody or specific binding protein to recognize the second biological particle that is bound to the first biological particle which is bound to the metal surface.
Brief Description of the Drawings Fig. 1 is a sectional elevation view of the apparatus in accordance with this invention showing a substrate having second biological particles bound to the first biological particles within the monomolecular layer of protein.
Fig. 2 in a sectional elevation view of the apparatus in Fig. 1 having a third biological particles bound to the second biological particles.
Fig. 3a is a view, partially cut away, of the apparatus in accordance with one embodiment of this invention for examining the finished substrate. The photon counting system is some distance away from the substrate to allow the exciting particles to be reflected by the metal surface toward the dark enclosure which will absorb all the photons that hit it, while even more induced signal from the substrate may travel toward the photon counting system due to reflection.
Fig. 3b is a partial perspective view similar to 3a. The 31 now is a electron gun and the substrate 30 is positively charged and connected to a constant voltage by means of a metal brash 33. In Fig. 3b, only the contact partion between brash 33 and metal surface 30' are shown in detail. A hole 34 is provided in the back wall of the dark enclosure 35 in order that light can be directed on metal surface 30' therethrough.
Fig. 4 is a sectional elevation view of the apparatus in Fig. 1 having fourth biological particles bound to the second biological particles bound to the first biological particles.
Fig. 5 is a sectional elevation view of the apparatus in Fig. 1 having the third biological particles bound to the first biological particles.
After some biological particles of interest (second biological particle) are bound to the first layer of protein, the substrate is as shown in Fig. 1 with substrate 10, metal surface 11 , first biological particles 12, second biological particle 13. A biological particle, most probably the antibody of the second biological particle is conjugated with fluorescent dye. A drop of this fluorescent antibody (third biological particle) solution is applied to the substrate that has second biological particle as shown in Fig. 1. The substrate is then preferably stored in a moist chamber for a time interval sufficient so that the fluorescent antibody will react with the second biological particle. The substrate after this reaction is shown in Fig. 2.The amount of the bound fluorescent antibody 14 will be proportional to the amount of the second biological particle present on the substrate 30.
The apparatus, arranged as shown in Fig. 3 is in a closed box with a light source 31 that is used to induce fluorescent emission from the substrate 30. The photon from 31 after hitting the substrate 30, which has a reflective metal surface, will be reflected toward the wall of the enclosure and trapped, while the induced signal will be detected by the photon counting system 32 that is used to measure the quantity of this fluorescent emission.
Since a constant light source is used, the signal detected at photon counting system 32 is proportional to the amount of fluorescent antibody 14 at the substrate. Because of this newly invented apparatus the biological particle of interest (second biological particle) needs not form a layer in order to be detected. The second biological particles are bound to the first layer or protein. Since the second biological particle need not form a layer to be detected, the first biological particle need not occupy the whole layer.
Therefore, the first layer of protein need not be a highly purified one. All these are definitely advantages compared to U.S. Patent No.
3,926,564 and U.S. Patent No. 4,011,308.
A further advantage is that the signal detection in this method is not related to the size of the biological particle.
This apparatus and method can detect both large biological particles (comparable to U.S.
Patent 3,853,467) and small biological particles (comparable to U.S. Patent 3,926,564). It can also detect smaller particles like steroid hormone and polypeptide. The conjugated fluorescent dye may be derived from (A) Fluorescein Derivatives, the most commonly used of which are fluorescein isocyanate (FIC) and isothiocyanate (FlTC), (B) Rhodamine derivatives, the most commonly used of which are rhodamine isocyanate and isothiocyanate, lissamine rhodamine B200 sulfonyl chloride (RB200XC), and (C) 1 Dimethyl-'aminonaphthaline-5-sulfonyl chloride (DANSC); these dyes are commercially available (for example, Baitimore Biological Lab) and some fluorescent dye conjugated antibodies are also commercially available.For different dyes, a different light source and different photon detecting device should be used. The most intensified light source is laser. One may also use arc lamps with a light wavelength selecting device or tungsten lamps with a iight wavelength selecting device to selected the favorable wavelength. The highly reflective surface of the invention reflects the exciting photons away from photo counting system 32 so avoiding a mixture of exciting photons and induced signal. The yreater the mixture, the more noise there is. The higher the signal to noise ratio, the more reliable the test results are.No matter what light source is used, the photon detecting device also needs a wavelength selecting device to further selected the fluorescent emissions, which may be mixed with a small amount of exciting photon however because of the reflecting device, the signal to noise ratio is greatly increased. The wavelength selecting device may be a monochromator or filter.
The exciting signal disclosed in this invention need not be limited to photon. It amy be neutron and the induced signal may be y-Ray (as is known neutron activation analysis) or other radiation, it may also be electrons or other charged particles and the induced signal may well by the characteristic X-ray if the third biological particle is labeled with some specific elements. For example, one of the metal label will be ferritin which are commercially available and the most economic changed particle will be electron. In this arrangement, the metal surface is positively changed and connected to a constant voltage as shown in Fig. 3b. By this way this metal surface will serve as the electron trap. A similar photon counting system may be used to detect the induced signal from the iron element.
The amount of the induced signal to be measured can be manipulated by changing the quantity of the exciting signal. According to this invention, the exciting particle are directed away from the signal detecting system, so that the signal is greatly increased without significant increase of the noise. In the apparatus disclosed, a metal covered substrate without biological particles will give few noise counts. This is an improvement over the prior art using emanation of a signal from a source which has a constant value depending on the specific activity. Besides, emanation will decrease with time, sometimes at very short half life, and is therefore more difficult to work with. Having a induced signal is definitely an advantage of this invention over U.S, Patent No. 4,011,308.
For induced signal, the natural background can be measured by turning off the exciting signal therefor, there is no need to deposit the biological particle to form a special pattern as required by U.S. Patent No. 4,011,308. The count outside the pattern is what is meant by the natural background.
Using the disclosed apparatus, it was possibie to study a trace amount of the third biological particle on the metal surface since it was discovered that the third biological particle need not form a layer to be detected, and neither does the second biological particle or the first biological particle. Partially purified first biological particle (for example, after ammonium sulfate precipitation) was used as the first layer. The small amount of second biological particles will extend fron the metal surface, and so will the third biological particles. This an advantage compared to the use of layers because the particles of interest extending into the solution will facilitate the specific reaction and reduce the non-specific binding. Both the time for performing such a test and the amount of non-specific binding will be greatly reduced.Among the other advantages of this method compared to U. S. Patent No.
4011308 and U. S. Patent No. 3926564 in which the first, second or the third biological particles are forming layer so as to be detected (Giaever Slides) are: 1) Only a very small amount (about 1/1000 of that used by Giaever) of first biological and second biological particle is needed to perform a test. The first biological particles may be partially purified ones which are much easier to obtain and are therefore much cheaper. 2) Effect of equilibrium constant: If the first biological particles form a layer, a binding with the metal is needed to prevent these particles form dissolving and a large amount of first biological particle is required to achieve this.
When second biological particles also form a layer, it is the binding between the first and the second biological particles that prevent the second biological particles from dissolving.
However, during the formation of the second biological particle layer, there is a minimum concentration requirement of second biological particle in the solution. Below this minimum concentration, the second biological particle layer cannot be formed. This will greatly decrease the resolution of the test. In the disclosed method, there is no second biological particle layer. The amount of first biological particle in the protein layer may also vary dependent on degree of purification, or on addition of different amounts of inert protein such as BSA. The best resolution is much more sensitive and its limits depend on the amount of the third biological particle that can be measured accurately.
The apparatus shown in Fig. 3a, which will be further discussed, is the key for the application of this disclosed method. The most important feature of the apparatus shown in Fig. 3a is that the metal substrate is used as part of the apparatus. There should be nothing in the path of the exciting photon which starts from light source 32 and ends at the wall of the dark enclosure except the highly reflective metal surface and the biological particles that are on it. With the incident angle being equal to the reflecting angle and the signal detecting system being perpendicular to and at some distance away from the substrate, the exciting particle will not be scattered toward the detecting system.The enclosure may also have a specially designed configuration to increase the trapping ability, so that almost all the exciting particle reflected toward the weil-designed trap will stop there and will not be detected by the signal counting system. The induced signal that starts from the third biological particle after the absorption of the exciting particle may travel in any direction and some will go to the photon counting system depending on the collecting apperture of the photon counting system. Because of the highly reflective metal surface, those induced photons that travel directly away at opposite direction from the photon counting system may also be reflected backward and enter the photon counting system. The disclosed apparatus is designed especially for a highly reflective substrate and whether it is a metal covered one is not essential.
A metal covered substrate is just one of the most convenient substrate. For example, a thin layer of gel on the metal covered substrate will also be a good substrate. Whether the bound molecules are protein molecules or not is not essential either, this apparatus may also apply to other molecules or a thin tissure slice and many other things that are attached to such a highly reflective substrate by drying, chemical reaction, adhesion, binding or other means.
The disclosed apparatus also allows for a very high intensity light source to be used on a dry sample as in the present case. Because of the highly reflective metal surface, very little photon absorption (that will be converted to heat) will occur on the substrate, therefore there is little chance of fading or damaging the sample. For this reason, even laser may be used as the light source. All these are definitely advantageous compared to U. S. Patent Nos. 4,056,724 and 4,036,946.
There will be different ways to bind the first biological particles to the substrate. For a metal covered substrate, a general immersing step may be used, and similarly for the binding of second biological particles to the first biological particle and the binding of the third biological to the second biological particle (the first biological particle in Fig. 5). To speed up the test, the sample may be dried on the substrate. To reduce the non-specific binding, the solution will be prevented from drying by keeping the substrate in a moisture chamber. There are many other modifications which may be used such as confining the sample in a small tube to limit the contact with the substrate in a small area, or using a breaker to enlarge the volume of the sample solution. No matter which way is used, washing the finished substrate is essential.
Because the metal surface will bind the first biological particles, the first biological particles will bind the second biological particles and so on, the washing will remove the nonspecific binding but not the specific reaction. However for glass, plastic and many other substrates there is no binding between first biological particles and the substrate, and the wash then may randomly remove the specific reaction while no wash will keep the non-specific reaction on the substrate and therefore will make the quantitative measurement impossible.
Besides, such substrates are not highly reflective and will not be able to have good resolution in the discloses apparatus.
To increase the quantitative resolution of the test and refine the reaction, a substrate of equal area and the same amount of sample solution should be used in one set of test.
The absorption and emission spectra of most of the fluorescent compounds used in protein tracing were reported by Hansen PA (1964) [Publication from University of Maryland College Park, Maryland]. The peak wavelength of the filter or monochromator to be used should follow this data. However, it was found that on using one piece of commercially available (Oriel Corporation) narrow band interference filter which as a transmission outside a pass band of 0.01%, this is not good enough to measure a trace amount of third biological particle on the substrate, because the noise of the instrument (to read a bare metal surface) is still high.
On using two pieces of such narrow band filter as a group for both the exciting signal filter and the induced signal filter, the resolution becomes very good and the noise of the instrument becomes non-detectable.
Both the absorption and emission band are very broad according to Hansen, and become even broader when attached to a metal surface according to the invention. The exact peak wavelength for these narrow band interference filters is not important. However it was found that it is better to have two pieces of filter used as a group to have the same peak wavelength and similar band width.
When a laser is used as the light source the exciting signal filter need not be used.
Monochromators are an excellent way to select the exciting signal, expecially when high intensity light sources are used.
It is easy to produce antibody to antibody of other species. For example, one may easily produce goat antibody to rabbit y-globulin by injecting y-globulin of rabbit into goat, and vice versa. The goat antibody to rabbit y-globulin bind rabbit antibody and the rabbit antibody to goat p- globulin will bind the goat antibody. Therefore the fluorescent antibody need not bind directly to the second biological particle, it may come after the fourth biological particle, as shown in Example 2.
The fluorescent antibody to complement may also be used as the third biological particle, if the second biological particle is the antibody to the first biological particle. The amount of bound complement will be proportional to the amount of bound second biological particle.
Example 1 The first layer protein contains HCG (human chorionic gonadotropin), the second biological particle is rabbit antibody to HCG. The third biological particle is fluorescant dye conjugated goat antibody to rabbit y-globulin. The finished substrate is shown in Fig. 2: HCG-1 2, rabbit antibody to HCG 13, fluorescent dye conjugated goat antibody to rabbit 1,-globulin 14.
Example 2 The detection of HCG antibody may also be done by fluorescent dye conjugated rabbit antibody to goat 1;-globulin. The first layer protein contains HCG, second biological particle is rabbit antibody of HCG. Before the third biological particle (fluorescent dye conjugated rabbit antibody to goat y-globulin) is applied to the substrate, the fourth biological particle (goat antibody to rabbit y-globulin) is applied. The finished substrate is shown in Fig. 4: HCG 12, rabbit antibody to HCG 13, goat antibody to rabbit y-globulin 15, fluorescent dye conjugated rabbit antibody to goat j'-globulin 1 6.
Example 3 Another way to detect HCG antibody is to use fluorescant dye conjugated rabbit antibody to HCG as the third biological particle. The finished substrate is shown in Fig. 5 with HCG 1 2, rabbit antibody to HCG 1 3, fluorescent dye conjugated rabbit antibody to HCG 23. An increased amount of 13 will reduce the amount of 23.
Example 4 To detect the HCG, we may use HCG as the first biological particle, rabbit antibody to HCG as the second biological particle, fluorescent dye conjugated goat antibody to rabbit y-globulin as the third biological particle. When we immerse the substrate with first layer of protein into the fluid of interest to determine the amount of HCG in it, we may add known amount of rabbit antibody to the fluid, this added antibody may bind either the HCG on the substrate or HCG in the solution. The amount of HCG on the substrate is a constant, the more HCG is in the solution, the less the amount of antibody which binds to the substrate. The finished substrate is the same as Example 1. A similar method may also be applied to Example 2, or Example 3 to detect the amount of HCG in a fluid.
Example 5 To detect HCG, we may use rabbit antibody to HCG as the first biological particle, HCG as the second biological particle, and fluorescent dye conjugated rabbit antibody to HCG as the third biological particle. The finished substrate is shown in Fig. 2 with rabbit antibody to HCG 12, HCG 13, fluorescent dye conjugated rabbit antibody to HCG 14. This method is especially useful to detect large biological particle like virus, bacteria and cells. (All the biological particles used in these examples are from Baltimore Biological Laboratory).

Claims (41)

Claims
1. Apparatus for detecting biological particles of a particular species in a fluid comprising a substrate having a metal film surface on which has been deposited an immunologic coating of at least one layer which comprises a layer of protein or protein bound particle absorbed on said metal film surface with first biological particle randomly distributed therein, means for applying some third biological particles bound thereto means for producing exciting particles and means to direct said exciting particles toward said third biological particles; means for measuring the quantity of induced signal from said third biological particle and means to direct the exciting particle which have effected excitation away from the quantity measuring means, said third biological particle comprises a label from which said induced signal can be induced by said exciting particles.
2. The apparatus of claim 1 wherein: said third biological particle comprises a fluorescent dye bound to a biological particle, said exciting particles are photons, said means to direct said exciting particle comprises means for directing photons, said means for measuring the quantity of said induced signal comprises means to measure the quantity of fluorescent emission, said means to direct said exciting photons away from the quantity measuring means comprises said metal surface and a photon trap.
3. The apparatus of claim 2 including additional means for directing photons onto the metal film surface of said substrate.
4. The apparatus of claim 3, wherein said means for drecting photons onto the metal film surface of said substrate comprises an enclosure having first and second end members wherein: a photon source within said enclosure adjacent to said first end member, said second member comprises means attached to a surface of said substrate to let the photons to be directed on it, said enclosure also comprises said photon trap.
5. The apparatus of claim 4 further including means in the enclosure for receiving the fluorescent emission.
6. The apparatus of claim 4, wherein said photon source comprises a laser.
7. The apparatus of claim 2, wherein said photon source comprises a lamp and a wavelength selecting device.
8. The apparatus of claim 5, wherein said means comprise a photon counting system and a wavelength selecting device.
9. The apparatus of claim 7, wherein said wavelength selecting device comprises a monochromator.
10. The apparatus of claim 7, wherein said wavelength selecting device comprises a filter.
11. The apparatus of claim 2, wherein said fluorescent dye comprises a fluorescein derivative.
12. The apparatus of claim 11 , wherein said fluorescein derivative is fluorescein isothiocya nate.
13. The apparatus of claim 2, wherein said fluorescein dye comprises a rhodamine derivative.
14 The apparatus of claim 13, wherein said rhodamine derivative is tetra methyl rhodamine isothiocyanate.
1 5. The apparatus of claim 13, wherein said rhodamine dye derivative is lissamine rhodamine B 200 sulfonyl chloride.
1 6. The apparatus of claim 2, wherein said fluorescent dye is 1-dimethylaminonaphthalene5-sulfonyl chloride.
17. Method for detecting biological particles of a particular species in a fluid which comprises the steps of: immersing a substrate having a metal surface into a solution of first biological particle, salt and other kinds of protein for sufficient time to absorb a monomolecular layer of protein, removing unbound protein by washing said substrate with water, immersing said substrate having said monomoleculaylayer of said protein thereon into said fluid whereby some of a second biological particle, if present in said fluid, is bound to said first biological particle; means to apply third biological particle over the said substrate having said first biological particle and said second biological particle; removing unbound particles by washing said substrate with water, examining said substrate by directing exciting particles toward said substrate, directing the exciting particles away from the quantity measuring means and directing the resulting induced particles toward said quantity measuring means to determine the quantity of the induced signal from the said substrate.
1 8. The method of claim 17, wherein the step of applying third biological particle is comprised of immersing said substrate having said first biological particle and said second biological particle if present into a solution of the third biological particle to let the third biological particle bind to said substrate, and removing unbound particles by washing said substrate with water.
19. The method of claim 17, wherein the step of applying third biological particle is comprises of immersing said substrate having said first biological particle and said biological particle if present into a solution of fourth biological particle to let it bind to said biological particle, immersing said substrate having said first biological particle, said biological particle and said fourth biological particle into a solution of third biological particle to let said third biological particle bind to said fourth biological particle, removing unbound particles by washing said substrate with water.
20. The method of claim 18, wherein: said biological particle is antibody to said first biological particle, said third biological particle is fluorescent dye conjugated antibody to said biological particle.
21. The method of claim 18, wherein: said first biological is antibody to said biological particle, said third biological particle is fluorescent dye conjugated antibody to said biological particle.
22. The method of claim 18, wherein: said biological particle is antibody to said first biological particle, said third biological particle is fluorescent dye conjugated antibody to the complement of the complex of said first and biological particle.
23. The method of claim 19, wherein: said fourth biological particle comprises antibody to said biological particle, said third biological particle is antibody to said fourth biological particle.
24. The method of claim 18, wherein: said biological particle is a specific binding molecular to said first biological particle, said third biological is fluorescent dye conjugated antibody to said biological particle.
25. The method of claim 18, wherein: one of said first biological particle and said biological particle is the antibody of the other particle, said third biological particle is the fluorescent dye conjugated said biological.
26. The method of claim 18, wherein: one of said first biological particle and said biological particle is the specific binding molecular of the other particle, said third biological particle is the fluorescent dye conjugated said biological particle.
27. The method of claim 18, wherein the examining step more particularly comprises: turning on the exciting particle source, directing the exciting particle source, directing the exciting particle from the source to the area on said substrate where said third biological particle if present has been bound.
28. The method of claim 18, wherein said examining step more particularly comprises directing said exciting particles toward said substrate, arranging the substrate to direct the exciting particles toward the trap, receiving and integrating induced signal from said substrate and indicating the integral quantity of said induced signal to provide a measure of the concentration of said biological particle in said fluid.
29. The apparatus of claim 8, wherein said wavelength selecting device comprises a monochromator.
30. The apparatus of claim 8, wherein said wavelength selecting device comprises a filter.
31. The method of claim 17, wherein said exciting particle are photons and said induced signal comprises fluorescent emission.
32. The apparatus of claim 4, wherein said first member and said second member are so arranged that said excitation photons that enter enclosure will hit said metal surface and are reflected toward said photon trap.
33. A fluorometric testing apparatus comprising a highly reflective substrate having a surface portion for receiving a sample, means to produce exciting photons and means to direct said exciting photons toward said sample, means for measuring the quantity of the induced photon from said sample, and means to direct the exciting photons which have effected excitation away from the quantity measuring means, means to measure the quantity of the induced photon from said sample.
34. The apparatus of claim 33 wherein said highly reflective substrate comprises metal cover substrate, said means to produce exciting photons comprises a wavelength selecting device and a light source, said means to direct exciting photons away from the quantity measuring means comprises said metal covered substrate and a photon trap, said means for measuring the quantity of induced photon comprises a wavelength selecting device and a photon counting system.
35. The apparatus of claim 34 wherein said excitation photon after hitting said substrate will be reflected toward said photon trap.
36. The apparatus of claim 35 wherein: said wavelength selecting device of said means for measuring the induced photon comprises two pieces of narrow band interference filters with similar peak wavelength.
37. The apparatus of claim 1 wherein said third biological particle comprises a metal bound to a biological particle. Said exciting particle is electron said means to direct said exciting particle comprise electric and magnetic field. Said means for measuring the quantity of said induced signal comprise means to measure the quantity of induced photon. Said means to direct said exciting electron away from quantity measuring means comprise said metal surface which are positively charged and connected to an electron trap.
38. The apparatus of claim 37, wherein said third biological particles comprise ferritin conjugated biological particle.
39. A testing apparatus for measuring electron induced photon from a sample comprise a conducting surface for receiving sample. Means for producing electrons, means for directing the electron toward said sample. Positively charged current source connected to said conducting surface for trapping said electrons means for measuring the quantity of the induced photon from said sample.
40. An apparatus for detecting biological particles substantially as hereinbefore described with reference to the accompanying drawings.
41. A method for detecting biological particles substantially as hereinbefore described with reference to the accompanying drawings.
GB7942836A 1979-12-12 1979-12-12 Method and apparatus for detecting biological particles by induced signal Expired GB2065298B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7942836A GB2065298B (en) 1979-12-12 1979-12-12 Method and apparatus for detecting biological particles by induced signal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942836A GB2065298B (en) 1979-12-12 1979-12-12 Method and apparatus for detecting biological particles by induced signal

Publications (2)

Publication Number Publication Date
GB2065298A true GB2065298A (en) 1981-06-24
GB2065298B GB2065298B (en) 1985-02-20

Family

ID=10509792

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7942836A Expired GB2065298B (en) 1979-12-12 1979-12-12 Method and apparatus for detecting biological particles by induced signal

Country Status (1)

Country Link
GB (1) GB2065298B (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117019A1 (en) * 1983-01-05 1984-08-29 Ortho Diagnostic Systems Inc. Immunoassay methods employing patterns for the detection of soluble and cell surface antigens
GB2181840A (en) * 1985-10-16 1987-04-29 Farmos Group Ltd Method for the immunoassay of a macromolecular analyte
GB2255637A (en) * 1991-03-20 1992-11-11 Marconi Gec Ltd Separation method for use in immunoassay
GB2270976A (en) * 1992-09-18 1994-03-30 Marconi Gec Ltd Immunoassay/separation process using an auxiliary species on a support
US5418136A (en) * 1991-10-01 1995-05-23 Biostar, Inc. Devices for detection of an analyte based upon light interference
US5482830A (en) * 1986-02-25 1996-01-09 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5494829A (en) * 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5541057A (en) * 1989-09-18 1996-07-30 Biostar, Inc. Methods for detection of an analyte
US5550063A (en) * 1991-02-11 1996-08-27 Biostar, Inc. Methods for production of an optical assay device
US5552272A (en) * 1993-06-10 1996-09-03 Biostar, Inc. Detection of an analyte by fluorescence using a thin film optical device
US5639671A (en) * 1989-09-18 1997-06-17 Biostar, Inc. Methods for optimizing of an optical assay device
US5955377A (en) * 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
US6395483B1 (en) 1999-09-02 2002-05-28 3M Innovative Properties Company Arrays with mask layers
US6482638B1 (en) 1999-12-09 2002-11-19 3M Innovative Properties Company Heat-relaxable substrates and arrays
US6492133B1 (en) 2000-05-01 2002-12-10 3M Innovative Properties Company Reflective disc assay devices, systems and methods
US7189842B2 (en) 1998-04-13 2007-03-13 3M Innovative Properties Company High density, miniaturized arrays and methods of manufacturing same
WO2008072156A2 (en) 2006-12-12 2008-06-19 Koninklijke Philips Electronics N. V. Microelectronic sensor device for detecting label particles

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117019A1 (en) * 1983-01-05 1984-08-29 Ortho Diagnostic Systems Inc. Immunoassay methods employing patterns for the detection of soluble and cell surface antigens
GB2181840A (en) * 1985-10-16 1987-04-29 Farmos Group Ltd Method for the immunoassay of a macromolecular analyte
GB2181840B (en) * 1985-10-16 1989-11-29 Farmos Group Ltd Method for the immunoassay of a macromolecular analyte
US5482830A (en) * 1986-02-25 1996-01-09 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5639671A (en) * 1989-09-18 1997-06-17 Biostar, Inc. Methods for optimizing of an optical assay device
US5541057A (en) * 1989-09-18 1996-07-30 Biostar, Inc. Methods for detection of an analyte
US5629214A (en) * 1989-09-18 1997-05-13 Biostar, Inc. Methods for forming an optical device for detecting the presence or amount of an analyte
US5869272A (en) * 1989-09-18 1999-02-09 Biostar, Inc. Methods for detection of gram negative bacteria
US5550063A (en) * 1991-02-11 1996-08-27 Biostar, Inc. Methods for production of an optical assay device
US5955377A (en) * 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
GB2255637B (en) * 1991-03-20 1995-11-15 Marconi Gec Ltd Separation method
GB2255637A (en) * 1991-03-20 1992-11-11 Marconi Gec Ltd Separation method for use in immunoassay
US5418136A (en) * 1991-10-01 1995-05-23 Biostar, Inc. Devices for detection of an analyte based upon light interference
US5494829A (en) * 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5631171A (en) * 1992-07-31 1997-05-20 Biostar, Inc. Method and instrument for detection of change of thickness or refractive index for a thin film substrate
GB2270976A (en) * 1992-09-18 1994-03-30 Marconi Gec Ltd Immunoassay/separation process using an auxiliary species on a support
US5552272A (en) * 1993-06-10 1996-09-03 Biostar, Inc. Detection of an analyte by fluorescence using a thin film optical device
US7189842B2 (en) 1998-04-13 2007-03-13 3M Innovative Properties Company High density, miniaturized arrays and methods of manufacturing same
US6593089B2 (en) 1999-09-02 2003-07-15 3M Innovative Properties Company Arrays with mask layers and methods of manufacturing same
US6664060B2 (en) 1999-09-02 2003-12-16 3M Innovative Properties Company Arrays with mask layers and methods of manufacturing same
US6395483B1 (en) 1999-09-02 2002-05-28 3M Innovative Properties Company Arrays with mask layers
US6482638B1 (en) 1999-12-09 2002-11-19 3M Innovative Properties Company Heat-relaxable substrates and arrays
US6492133B1 (en) 2000-05-01 2002-12-10 3M Innovative Properties Company Reflective disc assay devices, systems and methods
US6900028B2 (en) 2000-05-01 2005-05-31 3M Innovative Properties Company Reflective disc assay devices, systems and methods
WO2008072156A2 (en) 2006-12-12 2008-06-19 Koninklijke Philips Electronics N. V. Microelectronic sensor device for detecting label particles
WO2008072156A3 (en) * 2006-12-12 2008-08-28 Koninkl Philips Electronics Nv Microelectronic sensor device for detecting label particles
RU2487338C2 (en) * 2006-12-12 2013-07-10 Конинклейке Филипс Электроникс Н.В. Microelectronic sensor device for detecting label particles
US9658219B2 (en) 2006-12-12 2017-05-23 Koninklijke Philips N.V. Microelectronic sensor device for detecting label particles
US11243199B2 (en) 2006-12-12 2022-02-08 Siemens Healthineers Nederland B.V. Carrier for detecting label particles
US11402374B2 (en) 2006-12-12 2022-08-02 Siemens Healthineers Nederland B.V. Method of detecting label particles

Also Published As

Publication number Publication date
GB2065298B (en) 1985-02-20

Similar Documents

Publication Publication Date Title
US4222743A (en) Method and apparatus for detecting biological particles by fluorescent stain
US5266498A (en) Ligand binding assay for an analyte using surface-enhanced scattering (SERS) signal
US4923819A (en) Time-resolved fluorescence immunoassay
GB2065298A (en) Method and Apparatus for Detecting Biological Particles by Induced Signal
US4454233A (en) Method of tagged immunoassay
JP3444630B2 (en) Surface enhanced Raman spectrum immunoassay
JP5960098B2 (en) Sensitive system and method for the analysis of troponin
US10067126B2 (en) Use of fluorescence for the quick and easy determination of s-adenosylmethionine, s-adenosylhomocysteine and homocysteine
JP3458860B2 (en) Sensor device for sandwich analysis
US4341957A (en) Fluorescent antibody composition for immunofluorometric assay
JP2571971B2 (en) Analysis method and kit
CA1137410A (en) Double tagged immunoassay
JP2002303629A (en) Immune chromatography device and method for determining substance to be tested using the same
US20200333337A1 (en) Method for re-using test probe and reagents in an immunoassay
US4436826A (en) Tagged immunoassay
JP2005502871A (en) Particle homogeneous assay using laser-excited fluorescence detection capillary electrophoresis
WO1988007670A2 (en) Time-resolved fluorescence apparatus and immunoassay
JP4437211B2 (en) Measuring method using immunochromatography and sample analysis tool used therefor
EP3308167A1 (en) Use of fluorescence for the quick and easy determination of s-adenosylmethionine, s-adenosylhomocysteine and homocysteine
GB2136953A (en) Method and Apparatus for Detecting Biological Particles by Induced Signal
JP6325022B2 (en) Sensitive system and method for the analysis of troponin
DE3025022C2 (en) Method for the determination of biological particles by induced signals
JPS6217708B2 (en)
Uzgiris [11] Probing immune reactions by laser light scattering spectroscopy
Seare Immunoassay techniques

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee